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Rit is a novel member of the Ras superfamily of small GTP-binding proteins that regulates signaling pathways controlling cellular fate
determination. Constitutively activated mutants of Rit induce terminal differentiation of pheochromocytoma (PC6) cells resulting in a sympathetic
neuron-like phenotype characterized by the development of highly-branched neurites. Rit signaling has been found to activate several downstream
pathways including MEK/ERK, p38 MAPK, Ral-specific guanine nucleotide exchange factors (GEFs), and Rit associates with the Par6 cell
polarity machinery. In this study, a series of Rit effector loop mutants was generated to test the importance of these cellular targets to Rit-mediated
neuronal differentiation. We find that Rit-mediated neuritogenesis is dependent upon MEK/ERK MAP kinase signaling but independent of
RalGEF activation. In addition, in vivo binding studies identified a novel mechanism of Par6 interaction, suggesting that the cell polarity
machinery may serve to spatially restrict Rit signaling.
© 2007 Elsevier B.V. All rights reserved.Keywords: Neuronal differentiation; PC12 cell; Rit; GTPase; Ras; ERK MAP kinase; Par61. Introduction
The Ras superfamily of small GTPases is composed of more
than 200 members that act as molecular switches at key regu-
latory nodes to direct a variety of cellular functions [1]. Within
this varied superfamily, the Ras subfamily is particularly
important for the regulation of cellular proliferation, differen-
tiation, and survival [1–3]. The exchange of bound GDP for
GTP, stimulated by external cues that activate guanine nu-
cleotide exchange factors (GEFs), results in a conformational
rearrangement of the G-protein exposing previously buried
residues including a region known as the effector domain,
which is primarily responsible for the interaction with, and
activation of, downstream signaling partners [4–6]. Determin-
ing the identity of effector protein targets and understanding
how their activation leads to alterations in cellular function are
important goals in Ras-mediated signal transduction [7–10].⁎ Corresponding author. Tel.: +1 859 257 6775; fax: +1 859 323 1037.
E-mail address: dandres@uky.edu (D.A. Andres).
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doi:10.1016/j.bbamcr.2007.09.008One recently identified branch of the Ras subfamily is
composed of Rit, Rin and Drosophila Ric proteins [11,12].
These GTPases contain a unique effector binding domain and
lack the usual C-terminal signal for lipid addition, suggesting
that they may function to regulate signaling pathways distinct
from Ras [11,13]. Initially investigated for their abilities to
promote tumor formation in NIH 3T3 fibroblasts, only a con-
stitutively activated version of Rit, RitL79, was found to support
tumorigenic growth in a manner distinct from that for oncogenic
Ras [14,15]. However, like Ras, Rit binds and activates the Ral
GEF, RGL3, to activate Ral GTPase signaling [16].
While only Rit was found to promote NIH 3T3 cell trans-
formation, all members of this subfamily potently stimulate
differentiation in rat pheochromocytoma (PC12) cells [17–21].
PC12 cells are a well-defined model system that has been used
extensively to examine the extracellular stimuli and intracellular
signaling cascades that regulate neuronal differentiation [22–
28]. Nerve Growth Factor (NGF) stimulation promotes neurite
outgrowth in PC12 cells, induces differentiation and survival of
neurons in vivo, and leads to the activation of both Rit and Rin
GTPases [24,29–33]. Selective knock-down of either Rit or Rin
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(siRNA) methods significantly decreases neurite outgrowth and
activation of p38 MAP kinase signaling following NGF sti-
mulation [29,30]. RNAi studies have also demonstrated a role
for Rit in NGF-mediated ERK MAP kinase activation in PC6
cells [29].
More recently, Rit has been shown to interact with the cellular
polarity machinery by directly binding to Par6 [34]. The Par3–
Par6-atypical Protein Kinase C (aPKC) complex is a known
scaffold for directing apical–basal polarity in epithelial cells and
for axon-specification in neurons, at least in part through control
of Rho family-mediated actin remodeling [35–37]. GTP-bound
Rac1 and Cdc42 bind to the semi-Cdc42/Rac1 interactive
binding (CRIB) domain of Par6 [38]. Interestingly, GDP-bound
Rac1 also indirectly interacts with the Par3/6 scaffold,
associating with the Rac activator Tiam 1, which is a component
of the larger Par complex [39]. This association is necessary for
tight junction formation in keratinocytes as well as directing
neuronal polarity in hippocampal neurons [39,40]. Hoshino and
colleagues have shown that Rit directly associates with the PDZ
domain of Par6 in a GTP-dependent fashion, even though Rit
does not contain a consensus PDZ recognition site at its C-
terminus [34].While Par6 association has been found to promote
Rit-mediated NIH 3T3 cell transformation, the importance of
Par6 association to Rit-directed neuronal differentiation has not
been examined [34]. Since Rit-mediated neurite outgrowth has
been proposed to require Rac/Cdc42 activation, association with
the Par6 complex may play a critical role in both Rit-mediated
Rho-family activation and neuronal differentiation [19].
While it is clear that Rit family GTPase signaling is impor-
tant for appropriate PC6 cell and neuronal signaling, the
contribution of individual Rit-mediated effector signaling
pathways to this process remains unknown. To begin to under-
stand the consequences of Rit-dependent activation of these
distinct cellular signaling pathways, a series of alanine muta-
tions was made to the effector domain of constitutively acti-
vated Rit (residues 48 to 59). These Rit effector mutant proteins
were tested for their ability to induce PC6 cell differentiation
and to associate with, and activate, known Rit effector targets.
2. Materials and methods
2.1. Plasmids and reagents
Flag-tagged wild type, constitutively activated, and dominant negative Rit in
p3xFLAG-CMV-10 vector, and Glutathione-S-Transferase-tagged activated Rit
in the pEBG vector and wild-type Rit in the pGEX-KG vector have been
described previously [29,41]. Hemagglutinin-tagged pKH3 Par6A and Par6B
were the kind gift of Dr. Ian Macara, University of Virginia, Charlottesville, VA.
Par6C (or Par6α) was PCR isolated from Homo sapiens cDNA clone IMAGE:
4844008. ΔPDZ (residues 1–139) and ΔN (residues 154–345) mutants lacking
the PDZ domain or the amino terminus, respectively, were isolated by PCR. Full
length, ΔPDZ, and ΔN constructs were verified by sequence analysis by Agen-
court Bioscience Corp. (Beverly, MA). The following commercially available
antibodies were used: Flag (Sigma, Saint Louis, MO), GST (Santa Cruz
Biotechnology, Inc., Santa Cruz, CA), HA (12CA5), phospho-specific-ERK1/2
mouse monoclonal antibody and phospho-specific-p38 mitogen-activated
protein kinase (MAPK) mouse monoclonal antibody (Cell Signaling, Beverly,
MA). The GST-RGL3-RBD glutathione-agarose beads were prepared from
bacterially-expressed GST-RGL3-RBD as described previously [16,17,29]. Thefull-length biotinylated human Par6C (or Par6α) cDNA-PinPoint Xa-3 and
GST-tagged PKCι PB1 domain [PKCι-(1–113)]−pGEX-6P plasmids were
constructed previously [42].
2.2. Expression and purification of proteins
Expression and purification of biotinylated human Par6 protein has been
described previously [43]. Cmr plasmids carrying αA crystallin gene and GST-
PKCι-(1–113) pGEX-6P were co-transformed into Escherichia coli BL21
(DE3) and transformants were grown in LB containing 35 μg/ml chloramphen-
icol and 50 μg/ml ampicillin at 22 °C (220 rpm). At OD600 of 0.8, IPTG was
added to a final concentration of 0.1 mM and cells were harvested after 6 h of
induction. Soluble GST-tagged PKCι (1–113) protein was isolated using B-PER
GST Fusion Protein Purification Kit (Pierce, Rockford, IL) and dialyzed against
Tris buffer (50 mM Tris (pH 8.0), 135 mMNaCl, 10% glycerol). Expression and
purification of GST-Rit, as well as guanine nucleotide exchange, has been
described previously [13]. GDP- and GTPγS-bound GST-Rit were aliquoted
into 50 μg samples and frozen at −80 °C prior to use.
2.3. Cell lines, cell culture, and transfection
PC6 is a sub-line of PC12 that produce neurites in response to NGF, but
grow as well isolated cells in culture (the generous gift of Dr. T. C. Vanaman,
University of Kentucky, Lexington, KY). The cells were maintained in Dul-
becco's modified Eagle's medium (DMEM; Life Technologies, Carlsbad, CA)
supplemented with 10% (vol/vol) heat-inactivated fetal bovine serum (FBS;
HyClone, Logan, UT), 5% (v/v) heat-inactivated horse donor serum (HS; Life
Technologies), 100 μg/ml streptomycin and 100 U/ml penicillin at 37 °C in a
humidified atmosphere of 5% CO2. PC6 cells were transfected using Effectene
(Qiagen, Valencia, CA) as described previously [30,41]. COS cells were
obtained from American Type Culture Collection (Manassas, VA) and cultured
in DMEM supplemented with 10% (v/v) FBS, 100 μg/ml streptomycin and
100 U/ml penicillin at 37 °C in a humidified atmosphere of 5% CO2. Trans-
fection of COS cells was performed using Superfect (Qiagen) as described
previously [29].
2.4. Generation of Rit effector loop mutants
Nine effector loop mutants, each with one residue changed to alanine, were
produced in the constitutively active RitL79 background using the QuickChange
Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA). Successful mutation
was verified by DNA sequence analysis. The generation of RitL79S53 was
described previously [13].
2.5. Neurite induction
PC6 cells were exposed to the indicated Effectene–DNA complexes for 12–
16 h [41]. The cells were then diluted (1:4), re-plated, and subjected to G418
selection (Life Technologies, San Diego, CA). At day 3 after neurite induction,
cells were examined with a Zeiss Axiovert25 inverted phase-contrast microscope
using a 20× objective. The percentage of cells bearing neurites greater than one
cell body diameter was determined in three separate experiments. At least 150
cells in 10–15 random fields were counted for each condition. For representative
images of the mutants, cells were fixed at day 3 after neurite induction for 15 min
in fresh 4% paraformaldehyde, rinsed three times with phosphate buffered saline
(PBS), and permeabilized for 5 min in 0.1% Triton X-100 [44]. Cells were then
incubated for 1 h at room temperature with shaking in 1:1000 FITC-phalloidin
(Sigma, Saint Louis, MO) in 5% bovine serum albumin, washed three times in
PBS, and images captured with an Orca ER camera attached to a Zeiss Axiovert
200 M fluorescence microscope using a 32× objective.
2.6. MAP kinase immunoblotting
To examine ERK and p38MAP kinase activation, PC6 cells seeded in 6-well
plates were transfected with p3xFlag-RitL79, a p3xFlag-tagged effector loop
mutant, or empty p3xFlag vector as control. 48 h after transfection, cells were
starved for serum 5 h prior to the preparation of whole cell lysates. The
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immunoblotting with phospho-specific antibodies as described previously [29].
2.7. Immunoprecipitation, Glutathione-S-Transferase (GST) pull-down
analysis, and Par6 binding assay
To examine the ability of the Rit effector loop mutants to bind to a known
downstream target of Rit, the Ral GEF, RGL3, GST fusion proteins containing
the Rit binding domain of RGL3 (residues 610–709) were expressed and purified
as described previously [16,18,29,41]. PC6 cells seeded in 6-well plates were
transiently transfected with p3xFlag-RitWT, p3xFlag-RitL79, p3xFlag-tagged Rit
effector loop mutant, or empty p3xFlag vector and incubated for 36 h to allow
maximal expression. Cell monolayers were lysed in GST pull-down assay buffer
(20 mM HEPES [pH 7.4], 250 mM NaCl, 50 mM KF, 50 mM β-glycerol
phosphate, 1% Triton X-100, 10% glycerol, and 1× protease inhibitor cocktail)
with sonication. Insoluble material was pelleted by centrifugation. GST resin
(20 μgGST-RGL3-RBD/ 20 μL glutathione beads) was added to 200 μg lysate,
incubated for 1 h with end-over-end rotation at 4 °C, and the resin collected by
brief centrifugation. The pelleted beads were washed once with ice-cold GST
pull-down buffer, twice with ice-cold GST pull-down buffer supplemented with
500 mM NaCl, and twice with ice-cold GST pull-down buffer. Bound Rit
proteins were released by boiling in Laemmli sample buffer, separated by sodium
dodecylsulfate (SDS)–10% polyacrylamide gels, transferred to nitrocellulose
(Protran; Schleicher and Schuell Bioscience Dassel, Germany), and detected by
immunoblotting with Flag antibody.
To examine the Par6 isoform Rit binds, COS cells were transiently
transfected with pKH3-Par6A, pKH3-Par6B, or p3xFlag-Par6C and empty
GST vector or GST-RitL79. Cells were allowed to recover for 36 h after
transfection. Cells were harvested by scraping in ice-cold GST pull-down assay
buffer and lysed with sonication on ice. Insoluble material was pelleted by
centrifugation. Pre-washed glutathione-sepharose resin (GE Healthcare Bio-Fig. 1. Mutation of the Rit effector loop alters neurite outgrowth ability. (A) Sequenc
cells were transiently transfected, subjected to G418 (400 μg/ml) selection for 3 days
fluorescent micrographs from random fields are presented. (C) The percentage of n
(100%) as means±standard error from three independent experiments.sciences Corp., Piscataway, NJ) was added to 500 μg lysate in a total volume of
1 ml and incubated with end-over-end rotation for 2 h at 4 °C. The resin was
collected by brief centrifugation and the supernatant discarded. The resin was
extensively washed, twice with ice-cold GST pull-down buffer, once with ice-
cold GST pull-down buffer supplemented with 1 M NaCl, and twice with ice-
cold GST pull-down buffer. Bound proteins were released by boiling in
Laemmli sample loading buffer. Bound proteins and 10 μg total cell lysate from
each sample were resolved using SDS–10% polyacrylamide gels, transferred to
nitrocellulose, and detected by immunoblotting with hemagglutinin (HA), Flag,
or GST antibody.
To examine the ability of the Rit effector loop mutants, wild type, activated,
and dominant negative Rit to bind Par6C, cell lysates were generated from COS
cells transiently transfectedwith empty p3xFlag vector, p3xFlag-RitWT, p3xFlag-
RitL79, p3xFlag-RitN35, or p3xFlag-tagged effector loopmutant alongwith empty
GST vector, GST-Par6C, GST-Par6CΔPDZ, or GST-Par6CΔN. GST pulldowns
were performed with whole-cell lysates as described above.
To assess Rit binding to Par6 in vitro, recombinant biotinylated human Par6
protein was covalently bound to streptavidin-coated 96-well microtiter plates
(Nunc, Roskilde, Denmark) as described previously [42]. Purified GST-tagged
PKCι (1–113), GST-tagged GTPγS-bound Rit, GST-tagged GDP-bound Rit or
active unfused GST (Biovision, Mountain View, CA) was added to the wells at
the concentrations indicated and allowed to bind to Par6 overnight at 4 °C. Wells
were then washed twice with PBS-Tween 20 to remove unbound protein and
incubated with rabbit anti-GST polyclonal antibody (1:2500) (Chemicon Inter-
national) at room temperature for 2 h. After two washes with PBS-Tween 20,
Alexa Fluor® 532 goat anti-rabbit IgG (1:250, Invitrogen) was added to eachwell
and incubated at room temperature for 3 h. The wells were washed twice with
PBS-Tween 20, once with PBS, and binding determined by measuring fluo-
rescence intensity using a Typhoon 9410 imager (GE Healthcare Bio-sciences
Corp., Piscataway, NJ) and ImageQuant software (Amersham). Specific binding
was calculated as total binding minus binding of GSTat each concentration. Data
were analyzed using SigmaPlot (Systat Software, Inc).e alignment of the effector domains from several Ras family GTPases. (B) PC6
, fixed and stained with FITC-phalloidin to label actin filaments. Representative
eurite-bearing cells was calculated at day 3 and is presented relative to RitL79
Fig. 3. Rit effector loop mutants exhibit differential binding to RGL3-RBD. PC6
cells were transiently transfected with the indicated expression vectors, and the
cells starved with serum-free DMEM for 5 h prior to the preparation of whole
cell lysates. Cell lysates (200 μg) were incubated at 4 °C for 1 h with GST–
RGL3–RBD pre-bound to glutathione beads. The RGL3–RBD complexed
affinity beads were pelleted and washed extensively, and the amount of bound
Rit protein in the pellet fraction was determined by anti-Flag immunoblotting.
The expression of Rit present in each lysate was also determined by immunoblot
analysis. Blots are representative of three independent trials.
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3.1. Mutations within the Rit effector loop alter biological
activity
Effector domain mutants have proven to be useful reagents
for defining the contribution of specific effector pathways to the
actions of Ras and Rho family proteins, including their actions in
PC12 cell differentiation [7,45,46]. To examine the contribution
of known signaling pathways to Rit-mediated neurite outgrowth,
single amino acids within the effector domain (residues 48–59)
were mutated to alanine in the context of constitutively active
RitL79 (Fig. 1A). These double mutants were tested for their
ability to induce PC6 cell differentiation as measured by the
extension of neurites. Another Rit mutant, RitL79S53, previously
shown to allow preferential activation of Raf/MEK/ERK sig-
naling but not of RalGEF, was also examined [13]. Expression of
activated RitL79 in PC6 cells induced 10-fold higher neurite
formation than cells transfected with empty vector alone and
caused 1.5 times as many cells to exhibit neurites as wild-type
Rit (Fig. 1B, C). The neurite induction of the various effector
loop mutations could be classified into those with activity equal
to that of RitL79 (RitL79A48, RitL79A49), those with a significantly
reduced ability to induce neurite formation compared to wild-
type Rit (RitL79A54, RitL79A55, and RitL79A56), and those with an
intermediate phenotype with induction slightly greater than
wild-type Rit (RitL79A50, RitL79A51, RitL79S53, RitL79A58, and
RitL79A59). Since no single effector domain mutation was found
to completely disrupt Rit-dependent neuritogenesis, these data
suggest that activation of more than one effector pathway is
likely necessary for full neurite induction.
3.2. ERK activation correlates with neurite formation
Several pathways are known to be required for NGF-
mediated PC12 cell differentiation including the Raf/MEK/
ERK and p38 MAPK cascades [23,27,47,48]. Constitutively
activated mutants of Ras, Raf, and MEK are all capable ofFig. 2. Mutation of the Rit effector loop alters activation of downstream MAPK
pathways. PC6 cells were transiently transfected with expression vectors for the
indicated Rit mutant, subjected to serum starvation, and harvested as described
under Materials and methods. 50 μg of pre-cleared lysate was resolved on SDS
10%–polyacrylamide gels and the levels of activated ERK1/2 and p38 MAPK
were determined by immunoblotting with the appropriate phospho-specific
antibodies. Blots are representative of three independent trials.inducing neuronal differentiation in PC12 cells highlighting the
importance of this MAP kinase signaling cascade in cell fate
[17,27,49,50]. Expression of RitL79, but not the empty Flag
vector, increased the cellular levels of both phospho-ERK1/2
and phospho-p38 (Fig. 2) in PC6 cells, consistent with earlier
studies [29,30,51]. All of the Rit effector loop mutants appear to
be expressed to approximately equal levels (see Figs. 2 and 3)
suggesting that the alanine substitutions did not result in global
destabilization. Surprisingly, each of the Rit mutant proteins was
found to promote p38 MAP kinase activation to levels seen here
with RitL79 (Fig. 2, top panel) and with previous studies using
wild-type Rit [29]. These data indicate that none of these
substitutions disrupt the interaction(s) required for activation of
the p38 MAP kinase signaling cascade. The organization of
molecular complexes by protein scaffolds is one mechanism
known to confer specificity to MAP kinase cascades and may
contribute to Rit-dependent p38 signaling [52]. Thus, the nature
of the molecular machinery that links Rit and p38 remains to be
characterized and is a goal of ongoing studies.
Although each of the Rit mutants were expressed at com-
parable levels in PC6 cells (Fig. 2, lower panel), their ability to
stimulate ERK MAP kinase activity could be divided into three
groups: mutants that induce phospho-ERK1/2 to the same level
as RitL79 (RitL79A48, RitL79A49), mutations that impair Rit-
mediated ERK activation similar to the level of RitWT in pre-
vious studies (RitL79A54, RitL79A55, RitL79A56), and those with a
slight reduction in the ability to activate ERK (RitL79A50,
RitL79A51, RitL79S53, RitL79A58, RitL79A59) [29]. Importantly,
ERK activation mirrored the ability of individual effector loop
mutants to induce neuronal differentiation, consistent with
earlier studies suggesting a critical role for MEK-ERK signaling
in Rit-mediated neuritogenesis [17,29].
3.3. RGL3 binding is not required for Rit-mediated neurite
induction
Ral GEF proteins are downstream targets of both Ras and Rit
signaling [16,53]. The importance of Ral GTPase function to
neurite induction is currently unclear, with some studies sug-
gesting that Ral-mediated activation of the exocyst complex is
necessary for membrane fusion to drive protrusion of neurites,
Fig. 4. Rit interacts with Par6C in an effector loop dependent manner. (A) COS
cells were transfected with GST or GST-RitL79 and 3xHA-Par6A, 3xHA-Par6B,
or 3xFlag-Par6C, whole-cell lysates were generated, and GST pull-down assays
performed as described under Materials and methods. Precipitated Par6 proteins
were detected by immunoblot analysis using anti-HA, or anti-Flag antibodies.
Equal expression of Par6 proteins was detected from total lysates by
immunobloting. Blots are representative of three independent trials. (B) COS
cells were co-transfected with either unfused GST or GST–Par6C expression
vectors and the indicated Flag-tagged Rit mutants. Whole-cell lysates were
generated and GST pull-down assays performed as described under Materials
and methods. Precipitated Rit and Par6 protein was detected by immunoblot
analysis using anti-Flag and anti-GSTantibodies, respectively. Expression of Rit
protein was examined by anti-Flag immunoblotting of total lysate. Blots are
representative of three independent trials.
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by inhibiting Rho family GTPase-regulated cytoskeletal
reorganization [54,55]. Since the Ras/Rit Binding Domain
(RBD) of RGL3 is both necessary and sufficient for GTP-
dependent Rit binding, we examined the ability of Rit effector
loop mutants to associate with GST-RGL3-RBD by glutathione
bead precipitation [16]. As seen previously, both wild-type Rit
and RitL79 were found to potently bind RGL3-RBD [16]. This is
explained by the observation that overexpressed wild-type Rit is
predominantly GTP-bound and is thus able to both bind RGL3-
RBD and promote neurite outgrowth [17]. Unlike p38 acti-
vation, RGL3 association was particularly sensitive to effector
domain mutation. Only RitL79A49 and RitL79A55 displayed
robust RGL3-RBD association (see Fig. 3 lanes 4 and 9), while
both RitL79A48 and RitL79A59 exhibited weak but detectable
binding (Fig. 3 lanes 3 and 12). Interestingly, both RitL79A48 and
RitL79A49 induce neurite formation to the same extent (Fig. 1C),
which is significantly higher than that for RitL79A55, suggesting
that interaction with RalGEFs and activation of Ral signaling
are not required for Rit-mediated neurite induction.
3.4. Interaction of effector mutants with Par6 correlates with
neurite induction
Directing polarization of the actin cytoskeleton is critical for
initiating neurite formation and is controlled, in part, by the
Par3–Par6–aPKC complex, which localizes to the tips of
growing neurites [36,56–58]. Hoshino and colleagues first
described the interaction between GTP-Rit and the PDZ domain
of Par6, and found that Par6 synergistically enhanced RitL79-
dependent NIH 3T3 cell transformation [34]. Because of the
critical role for the Par complex in axonal growth, we next
examined whether Par6 contributes to Rit-mediated neuritogen-
esis [34,36]. There are three mammalian members of the Par6
family (Par6A–C), and while Hoshino and colleagues described
a Rit–Par6 interaction, it was unclear which isoform was used in
their studies [34,59]. To address this issue, we co-expressed GST
or GST-RitL79 and the three Par6 isoforms in COS cells and
assessed Par6 binding following glutathione resin precipitation.
GST-RitL79, but not unfused GST, interacted with all three Par6
isoforms (Fig. 4A). Because Par6C is preferentially expressed in
the brain, this isoformwas used in the remaining GST pull-down
assays [59].
To examine the effector-domain dependence of Par6C bind-
ing, cell lysates co-expressing either RitL79 or Rit effector loop
mutants and GST-Par6C or unfused GST were generated and
subjected to glutathione–sepharose bead pull-down analysis.
As expected, Flag-RitL79 bound to full length Par6C, but not
unfused GST (Fig. 4B). Unlike the strong correlation found
between ERK1/2 activation and PC6 cell differentiation, bind-
ing of the Rit effector mutants to Par6C did not clearly mirror
neurite induction. Those Rit effector mutants that promoted
robust neurite induction, RitL79A48 and RitL79A49, bound Par6C,
while mutants with significantly impaired neurite initiation
(alanine substitutions at residues 54–56) failed to bind Par6C,
suggesting that interaction with Par6C might contribute to Rit-
mediated neurite induction. However, Par6 association is notessential since RitL79S53 does not display appreciable Par6
binding (Fig. 4B) but promotes neurite formation (Fig. 1C). In
addition, except for RitL79S53, all the Rit effector mutants that
fail to bind Par6C also fail to activate ERK (Fig. 2). Thus, it not
possible to separate the relative contributions of these two
effector pathways to Rit function. Additional studies will be
necessary to more fully characterize the role of Par6 in Rit-
mediated neuronal signaling.
3.5. Characterization of an indirect Rit–GDP–Par6 interaction
Because this is the first reported interaction of Rit and Par6C,
we next examined the nucleotide dependence of binding.
Lysates expressing Flag-tagged wild-type Rit, RitL79, or RitN35
with GST-Par6C or unfused GSTwere generated and GST pull-
down assays performed. As expected, none of the Rit constructs
interacted with unfused GSTwhile both wild-type Rit and RitL79
displayed modest Par6C binding (Fig. 5A). Surprisingly,
dominant negative Rit, RitN35, a mutant which is predominantly
GDP-bound, does not promote neurite outgrowth, and fails to
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robust association with Par6C (Fig. 5A) [13,17,29]. Thus, in
addition to the previously characterized GTP-dependent inter-
action of Rit with the PDZ domain of Par6, these data suggestthat Rit associates with Par6C in a GTP-independent manner
[34].
To further characterize the GTP-independent interaction of
Rit with Par6, recombinant wild-type GST-Rit protein was pre-
loaded with either GDP or the non-hydrolyzable GTP analog,
GTPγS [13]. We took advantage of a well-established in vitro
human Par6C binding assay [42]. As seen in Fig. 5B, binding
studies were first performed with unfused GSTor GST-PKCι, an
established binding partner of Par6 [43]. As expected, no
association between GST and Par6 was observed whereas GST-
PKCι demonstrated strong binding with an apparent KD of
24.6 nM. Interestingly, both GDP- and GTPγS-Rit bound Par6
with approximately equal affinity (KD = 5.9 μM and
KD=7.3 μM, respectively) (Fig. 5C). These data support the
observations of Hoshino and colleagues that Rit can directly
bind Par6, albeit with a much lower binding affinity when
compared with GST-PKCι, a known component of the Par3–
Par6 complex [34,35]. Additionally, these data indicate that the
direct in vitro interaction between Rit and Par6 is GTP-
independent, since GDP- and GTPγS-bound Rit display
approximately equal binding (Fig. 5C). Moreover, they suggest
that the direct binding of GDP-Rit to Par6 does not account for
the robust binding of RitN35 to Par6 seen in whole cell lysates.
Indeed, the very low affinity observed for the in vitro binding of
Rit to Par6 suggests that the observed intracellular association is
likely not due to direct interaction, but instead is mediated by Rit
association to the larger Par6 scaffolding complex.
To begin to explore the nature of the RitN35–Par6C inter-
action, we examined which region of Par6 was bound by RitN35.
Lysates expressing Flag-tagged RitN35 and either GST-Par6C
(full-length: residues 1–345), GST-Par6CΔPDZ (residues 1–
139), or GST-Par6CΔN (Residues 154–345) were generated
and subjected to GST pull-down analysis. Surprisingly, RitN35
was found to bind all three Par6C constructs tested (Fig. 4D),
suggesting that the GTP-independent association of Rit with
Par6C does not require an intact PDZ domain [34].
Recently, the Rac1 GTPase has been shown to interact in a
complex fashion with the Par3/6 polarity complex. In this
case, active GTP-bound Rac1 binds to the semi-CRIB domain
of Par6 while GDP-Rac1 interacts with the Rho family GEF,
Tiam1, which associates with components of the larger Par3–
Par6–aPKC complex [39,40]. The Par/Tiam1 complex allows
for rapid and localized Rac1 activation following chemokineFig. 5. Dominant negative Rit strongly interacts with Par6 independent of its
PDZ domain. (A) COS cells were transfected with GSTor GST-Par6C and Flag-
tagged RitWT, RitL79 or RitN35. GST precipitations were performed as in Fig. 4B.
Note that RitN35 displays stronger association with Par6 than either RitWT or
RitL79. Blots are representative of three independent trials. (B, C) Biotinylated
Par6C was bound to streptavidin-coated plates and incubated with the indicated
concentrations of recombinant GST, GST-PCKι, or GST-Rit pre-loaded with
non-hydrolyzable GTPγS (GTP) or GDP. Binding isotherms for PKCι (B) and
GTPγS-Rit and GDP-Rit (C) to Par6 indicate that PKCι binds Par6 with much
higher apparent KD than Rit and that GTP- and GDP-Rit bind to Par6 with
similar affinities. (D) COS cells were co-transfected with GST, GST-Par6C full
length, GST-Par6CΔPDZ, or GST-Par6CΔN and Flag-RitN35 and whole cell
lysates were generated and subjected to GST pull-down analysis as described
under Materials and methods. Blots are representative of three independent
trials.
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mechanism by which Rap1 activation can control chemotaxis
[60]. Thus, it is tempting to speculate that dominant negative
Rit (RitN35) can associate with the Par3/6 complex in a
similar fashion, involving a scaffolded RitGEF protein. This
interaction would not have been detected in the study by
Hoshino and colleagues, since they examined the nucleotide-
dependence of the Rit–Par6 interaction with recombinant
proteins and additional cellular co-factor(s) would be absent
in their assays [34]. The possibility that the Par6 complex
contains a RitGEF is supported by the robust association seen
with RitN35, which bound more tightly than either wild-type
or activated Rit (Fig. 5A). Dominant-negative Ras GTPases
are preferentially bound by cellular GEFs but not by other
effectors which favor a GTP-bound conformational state [4].
Taken together, these data suggest that Rit–Par6 association is
unexpectedly complex, and may provide a novel mechanism
for regulating Rit activity. Indeed, we have recently found
that Rit is controlled by cross-talk between the NGF and
BMP signaling pathways and suggest a role for Rit in
regulating axonal and dendritic growth via activation of the
ERK MAP kinase signaling pathway [44]. Since the Par3/6
complex is involved in axon–dendrite specification in
hippocampal neurons [36], studies are currently underway
to further investigate the role of Par3/6 binding in Rit-
mediated control of axonal and dendritic growth.
In summary, using a series of Rit effector loop mutants we
have found that Rit-mediated neuronal differentiation depends
upon activation of the ERK MAP kinase cascade, but does not
require activation of RalGEF/Ral signaling. In addition, our
data demonstrate an unexpectedly complex association of Rit
with Par6 and suggests that the larger Par3/6/aPKC polarity
complex may contain a scaffolded RitGEF. Since Rit has
recently been shown to regulate axonal-dendritic growth via
activation of ERK MAP kinase signaling, it will be important
to examine the contribution of Par3/6 complex to the
regulation of this process.
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